BG101401A - Състави за орално приложение с удължено освобождаване на цисаприд - Google Patents

Състави за орално приложение с удължено освобождаване на цисаприд

Info

Publication number
BG101401A
BG101401A BG101401A BG10140197A BG101401A BG 101401 A BG101401 A BG 101401A BG 101401 A BG101401 A BG 101401A BG 10140197 A BG10140197 A BG 10140197A BG 101401 A BG101401 A BG 101401A
Authority
BG
Bulgaria
Prior art keywords
extended release
cisaspide
oral compositions
release oral
treatinggastrokinetic
Prior art date
Application number
BG101401A
Other languages
English (en)
Other versions
BG63244B1 (bg
Inventor
Eugene JANS
Paul Gilis
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of BG101401A publication Critical patent/BG101401A/bg
Publication of BG63244B1 publication Critical patent/BG63244B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Abstract

Изобретението се отнася до форми, съдържащи цисаприд-(L)-тартарат, по-специално за орално приложение, и до използването им в медицината при лечение на смущения в стомашно-чревната кинетика.
BG101401A 1994-11-02 1997-04-10 Състави за орално приложение с удължено освобождаване на цисаприд BG63244B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94203184 1994-11-02
PCT/EP1995/004198 WO1996014070A1 (en) 1994-11-02 1995-10-25 Cisapride extended release oral compositions

Publications (2)

Publication Number Publication Date
BG101401A true BG101401A (bg) 1997-12-30
BG63244B1 BG63244B1 (bg) 2001-07-31

Family

ID=8217338

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101401A BG63244B1 (bg) 1994-11-02 1997-04-10 Състави за орално приложение с удължено освобождаване на цисаприд

Country Status (29)

Country Link
US (2) US6153623A (bg)
EP (1) EP0789572A1 (bg)
JP (1) JP3182423B2 (bg)
KR (1) KR100255521B1 (bg)
AP (1) AP658A (bg)
AR (1) AR001765A1 (bg)
AU (1) AU704284B2 (bg)
BG (1) BG63244B1 (bg)
BR (1) BR9509565A (bg)
CA (1) CA2203663C (bg)
CZ (1) CZ287844B6 (bg)
EE (1) EE03510B1 (bg)
FI (1) FI971856A (bg)
HR (1) HRP950539A2 (bg)
HU (1) HUT77887A (bg)
IL (1) IL115843A0 (bg)
MY (1) MY113092A (bg)
NO (1) NO312538B1 (bg)
NZ (1) NZ295166A (bg)
OA (1) OA10419A (bg)
PL (1) PL181470B1 (bg)
RO (1) RO116042B1 (bg)
RU (1) RU2143890C1 (bg)
SK (1) SK54297A3 (bg)
TR (1) TR199501351A2 (bg)
TW (1) TW466114B (bg)
UA (1) UA50721C2 (bg)
WO (1) WO1996014070A1 (bg)
ZA (1) ZA959221B (bg)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release
WO1997020562A1 (en) * 1995-12-01 1997-06-12 Janssen Pharmaceutica N.V. Cisapride sustained release
ATE220543T1 (de) * 1996-04-23 2002-08-15 Janssen Pharmaceutica Nv Rasch-freisetzende ph-unabhängige feste dosisformen enthaltend cisaprid
CA2275604A1 (en) * 1997-01-03 1998-07-09 Kenneth Iain Cumming Sustained release cisapride mini-tablet formulation
CA2292628A1 (en) * 1997-06-11 1998-12-17 Janssen Pharmaceutica, N.V. Immediate release ph-independent solid dosage form of (+)- or (-)-cisapride
TW407058B (en) * 1998-07-17 2000-10-01 Dev Center Biotechnology Oral cisapride dosage forms with an extended duration
NZ514890A (en) 1999-03-31 2003-05-30 Janssen Pharmaceutica Nv Pregelatinized starch in a controlled release formulation
EP1060743A1 (en) * 1999-06-17 2000-12-20 Development Center For Biotechnology Oral cisapride dosage forms with an extended duration
RU2285519C2 (ru) 2000-09-29 2006-10-20 Солвей Фармасьютикалс Б.В. Фармацевтическая композиция с пролонгированным высвобождением, независимым от ионной силы
EP1364644B1 (en) * 2002-05-21 2008-09-17 Watson Laboratories, Inc. Pharmaceutical formulation with extended release
WO2007123021A1 (ja) 2006-04-12 2007-11-01 Nippon Soda Co., Ltd. 徐放性錠剤の製造方法
RU2356532C2 (ru) * 2007-06-01 2009-05-27 Открытое Акционерное Общество "Отечественные Лекарства" Фармацевтическая композиция проксодолола с контролируемым высвобождением
DK3045043T3 (da) 2009-02-26 2020-08-03 Relmada Therapeutics Inc Orale farmaceutiske sammensætninger af 3-hydroxy-n-methylmorphinan med forlænget frigivelse og fremgangsmåde til anvendelse

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
US5057525A (en) * 1981-10-01 1991-10-15 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl) benzamide derivatives
CA2132012C (en) * 1992-03-25 2003-04-22 John W. Shell Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
CA2139638A1 (en) * 1992-07-07 1994-01-20 Nancy M. Gray Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release

Also Published As

Publication number Publication date
PL181470B1 (pl) 2001-07-31
ZA959221B (en) 1997-04-30
EE03510B1 (et) 2001-10-15
JPH09511760A (ja) 1997-11-25
CZ287844B6 (en) 2001-02-14
NZ295166A (en) 1999-03-29
BG63244B1 (bg) 2001-07-31
PL319948A1 (en) 1997-09-01
AR001765A1 (es) 1997-12-10
SK54297A3 (en) 1997-10-08
HUT77887A (hu) 1998-09-28
FI971856A0 (fi) 1997-04-30
MY113092A (en) 2001-11-30
EE9700105A (et) 1997-12-15
TR199501351A2 (tr) 1996-06-21
AP9700969A0 (en) 1997-04-30
MX9703249A (es) 1997-07-31
OA10419A (en) 2001-12-06
EP0789572A1 (en) 1997-08-20
AU704284B2 (en) 1999-04-15
CA2203663C (en) 2002-04-30
NO971832D0 (no) 1997-04-21
AP658A (en) 1998-08-17
HRP950539A2 (en) 1997-08-31
US6274599B1 (en) 2001-08-14
RU2143890C1 (ru) 2000-01-10
AU3844795A (en) 1996-05-31
BR9509565A (pt) 1997-09-16
NO971832L (no) 1997-04-21
TW466114B (en) 2001-12-01
WO1996014070A1 (en) 1996-05-17
CA2203663A1 (en) 1996-05-17
RO116042B1 (ro) 2000-10-30
IL115843A0 (en) 1996-01-31
NO312538B1 (no) 2002-05-27
KR100255521B1 (ko) 2000-05-01
CZ124497A3 (en) 1997-08-13
FI971856A (fi) 1997-04-30
JP3182423B2 (ja) 2001-07-03
US6153623A (en) 2000-11-28
UA50721C2 (uk) 2002-11-15

Similar Documents

Publication Publication Date Title
EP0682945A3 (de) Orale Retard-Präparation.
EP0674898A3 (en) Shampoo composition.
ZA982253B (en) Therapeutic compositions.
TR199501447A2 (tr) Oral bilesimler.
AP9901534A0 (en) Pharmaceutical formulations.
ZA991544B (en) Dental abrasive.
HK1018780A1 (en) 6-Phenylpyridine-2-ylamine derivatives, the composition and use thereof.
SE9704546D0 (sv) Novel compounds
ZA964711B (en) Novel compounds, the preparation and use thereof.
ZA974735B (en) Pharmaceutical compositions.
ZA962939B (en) Oral care compositions.
IL114294A0 (en) Sterol derivatives
EP0590208A3 (en) Dental articulator.
EP0679333A3 (en) Non-sensitizing biocidal composition.
BG101401A (bg) Състави за орално приложение с удължено освобождаване на цисаприд
TR199501650A2 (tr) Agiz bilesimleri.
ZA977104B (en) Pharmaceutical compositions.
ZA987797B (en) Oral compositions.
ZA974270B (en) Pharmaceutical compositions based on diclofenac.
TR199501645A2 (tr) Agiz bilesimleri.
ZA9510506B (en) Anti-oxidant compositions.
EP0684038A3 (en) Deodorising preparations.
EP0508095A3 (en) Dental materials based on (meth)-acrylates
PL345204A1 (en) Compounds with growth hormone releasing properties
HK1040199A1 (en) Sertraline oral concentrate.